Naseem Amin is a director of Bellerophon Therapeutics, Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Bellerophon Therapeutics, Inc.
9 Jun 23
4
Bellerophon Therapeutics, Inc.
14 Feb 23
4
Bellerophon Therapeutics, Inc.
4 Jan 22
4
Bellerophon Therapeutics, Inc.
14 Sep 20
4
Bellerophon Therapeutics, Inc.
30 Sep 19
4
Bellerophon Therapeutics, Inc.
25 Jan 19
4
Bellerophon Therapeutics, Inc.
25 Jun 18
4
Bellerophon Therapeutics, Inc.
7 Jun 18
4
Bellerophon Therapeutics, Inc.
3 Oct 17
4
Bellerophon Therapeutics, Inc.
26 Sep 17
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
7 Jun 23 | BLPH Bellerophon Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 47,578 | 0.00 | 291,865 |
10 Feb 23 | BLPH Bellerophon Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 84,000 | 0.00 | 244,287 |